• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Patterns of Disease Progression after Carboplatin/Etoposide + Atezolizumab in Extensive-Stage Small-Cell Lung Cancer (ES-SCLC).

作者信息

Higgins K A, Curran W J, Liu S V, Yu W, Brockman M, Johnson A, Bara I, Bradley J D

机构信息

Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, GA.

Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.

出版信息

Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1398. doi: 10.1016/j.ijrobp.2020.09.020. Epub 2020 Nov 18.

DOI:10.1016/j.ijrobp.2020.09.020
PMID:33427656
Abstract
摘要

相似文献

1
Patterns of Disease Progression after Carboplatin/Etoposide + Atezolizumab in Extensive-Stage Small-Cell Lung Cancer (ES-SCLC).卡铂/依托泊苷联合阿替利珠单抗治疗广泛期小细胞肺癌（ES-SCLC）后的疾病进展模式
Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1398. doi: 10.1016/j.ijrobp.2020.09.020. Epub 2020 Nov 18.
2
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.阿替利珠单抗联合化疗一线治疗广泛期小细胞肺癌。
N Engl J Med. 2018 Dec 6;379(23):2220-2229. doi: 10.1056/NEJMoa1809064. Epub 2018 Sep 25.
3
Cost-effectiveness analysis of atezolizumab plus chemotherapy in the first-line treatment of extensive-stage small-cell lung cancer.阿替利珠单抗联合化疗一线治疗广泛期小细胞肺癌的成本效果分析。
Lung Cancer. 2019 Apr;130:1-4. doi: 10.1016/j.lungcan.2019.01.019. Epub 2019 Feb 1.
4
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.度伐利尤单抗联合铂类依托泊苷与铂类依托泊苷一线治疗广泛期小细胞肺癌（CASPIAN）：一项随机、对照、开放标签、III 期临床试验。
Lancet. 2019 Nov 23;394(10212):1929-1939. doi: 10.1016/S0140-6736(19)32222-6. Epub 2019 Oct 4.
5
A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer.一项I期试验，确定拓扑替康联合卡铂和依托泊苷在广泛期小细胞肺癌中的最大耐受全身暴露量。
Cancer Invest. 2005;23(6):511-9. doi: 10.1080/07357900500201400.
6
Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer.卡铂和依托泊苷联合或不联合甲磺酸 obatoclax 治疗广泛期小细胞肺癌的随机 II 期研究。
Lung Cancer. 2014 Sep;85(3):420-8. doi: 10.1016/j.lungcan.2014.05.003. Epub 2014 May 13.
7
Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer.培美曲塞联合卡铂与依托泊苷联合卡铂用于初治广泛期小细胞肺癌患者化疗的Ⅲ期研究
J Clin Oncol. 2009 Oct 1;27(28):4787-92. doi: 10.1200/JCO.2009.23.1548. Epub 2009 Aug 31.
8
Survival and Toxicity After Cisplatin Plus Etoposide Versus Carboplatin Plus Etoposide for Extensive-Stage Small-Cell Lung Cancer in Elderly Patients.广泛期小细胞肺癌老年患者顺铂联合依托泊苷与卡铂联合依托泊苷治疗的生存和毒性。
J Oncol Pract. 2016 Jul;12(7):666-73. doi: 10.1200/JOP.2016.012492. Epub 2016 Jun 28.
9
What is the role of radiotherapy for extensive-stage small cell lung cancer in the immunotherapy era?在免疫治疗时代，放疗对于广泛期小细胞肺癌的作用是什么？
Transl Lung Cancer Res. 2019 Sep;8(Suppl 2):S153-S162. doi: 10.21037/tlcr.2019.05.01.
10
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.度伐利尤单抗联合或不联合 Tremelimumab 与单用依托泊苷联合顺铂一线治疗广泛期小细胞肺癌（CASPIAN）：一项随机、对照、开放标签、3 期临床试验的更新结果。
Lancet Oncol. 2021 Jan;22(1):51-65. doi: 10.1016/S1470-2045(20)30539-8. Epub 2020 Dec 4.

引用本文的文献

1
Extensive-stage small cell lung cancer: Is prophylactic cranial irradiation necessary in the era of immunotherapy with MRI surveillance?广泛期小细胞肺癌：在采用MRI监测的免疫治疗时代，预防性颅脑照射是否必要？
Precis Radiat Oncol. 2023 Jun 21;7(2):111-117. doi: 10.1002/pro6.1200. eCollection 2023 Jun.
2
Progress in radiotherapy for small-cell lung cancer.小细胞肺癌放射治疗的进展
Precis Radiat Oncol. 2023 Jul 31;7(3):207-217. doi: 10.1002/pro6.1205. eCollection 2023 Sep.
3
Addition of thoracic radiotherapy to a PD-L1 inhibitor plus chemotherapy regimen delays brain metastasis onset in extensive-stage small cell lung cancer patients without baseline brain metastasis.
在程序性死亡受体 1 配体（PD-L1）抑制剂加化疗方案中加入胸部放疗可延迟广泛期小细胞肺癌且无基线脑转移患者的脑转移发生。
Respir Res. 2025 Mar 5;26(1):85. doi: 10.1186/s12931-025-03157-1.
4
Advances in the Management of Lung Cancer Brain Metastases.肺癌脑转移的治疗进展
Cancers (Basel). 2024 Nov 9;16(22):3780. doi: 10.3390/cancers16223780.
5
The Optimal Radiotherapy Strategy for Patients With Small Cell Lung Cancer and Brain Metastasis: A Retrospective Analysis.小细胞肺癌伴脑转移患者的最佳放疗策略：一项回顾性分析。
CNS Neurosci Ther. 2024 Nov;30(11):e70102. doi: 10.1111/cns.70102.
6
Strategies to Target Chemoradiotherapy Resistance in Small Cell Lung Cancer.针对小细胞肺癌放化疗耐药的策略
Cancers (Basel). 2024 Oct 10;16(20):3438. doi: 10.3390/cancers16203438.
7
The Era of Immunotherapy in Small-Cell Lung Cancer: More Shadows Than Light?小细胞肺癌免疫治疗时代：阴影多于光明？
Cancers (Basel). 2023 Dec 8;15(24):5761. doi: 10.3390/cancers15245761.
8
The efficacy of thoracic radiotherapy in extensive stage small cell lung cancer with baseline brain metastases: a multi-institutional retrospective cohort study.胸部放疗对伴有基线脑转移的广泛期小细胞肺癌的疗效：一项多机构回顾性队列研究
Ann Transl Med. 2023 Jan 31;11(2):60. doi: 10.21037/atm-22-5853.
9
First-Line Treatment for Advanced SCLC: What Is Left Behind and Beyond Chemoimmunotherapy.晚期小细胞肺癌的一线治疗：化疗免疫疗法之外还有什么。
Front Med (Lausanne). 2022 May 25;9:924853. doi: 10.3389/fmed.2022.924853. eCollection 2022.
10
A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada.加拿大广泛期小细胞肺癌患者使用阿替利珠单抗联合铂类-依托泊苷化疗的真实世界评估
JTO Clin Res Rep. 2021 Oct 28;2(12):100249. doi: 10.1016/j.jtocrr.2021.100249. eCollection 2021 Dec.